H&E, IHC anti- Cytokeratin

Similar documents
CC01 - Colon Cancer Tissue Microarray

LN04 - Lymphoma Tissue Microarray

George Cernile Artificial Intelligence in Medicine Toronto, ON. Carol L. Kosary National Cancer Institute Rockville, MD

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Testis/ovary germ cell tumor tissue array, 48 cases, 96 samples

ab Stomach cancer tissue array of 228 cases (1.1mm)

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

ab Pancreatic cancer tissue array, 24 cases, 48 samples (2mm)

3 cell types in the normal ovary

ab Colon cancer tissue array of 228 cases (1.1mm)

Staging and Treatment Update for Gynecologic Malignancies

3 cell types in the normal ovary

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

ab Prostate cancer tissue array, 24 cases, 48 samples (1.5mm)

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Carcinoma of the Fallopian Tube

MT09 - Normal Human Tissue Microarray, FDA

ab Colon cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 1

ab Endometrial cancer tissue array of 102 cases (1.5mm)

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Stage 3 ovarian cancer survival rate

Gastric Cancer Histopathology Reporting Proforma

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Stage 3 ovarian cancer survival rate

ab Ovary cancer tissue array of 102 cases (1.5mm)

ab Lung cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

ab Nervous system tumor tissue array, 48 cases, 96 samples (1.5mm)

Cancer: recent advances and implications for underwriting

Nasopharyngeal primary and metastatic carcinoma tissue array, 96 samples (1.5mm), set 1

ab Kidney cancer tissue array of 102 cases (1.5mm)

UICC TNM 8 th Edition Errata

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.

ab Head and neck tumor tissue array, 48 cases, 96 samples (1.5mm), set 1

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

ab Thyroid cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

ab Lung cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

Gynaecological Malignancies

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Institute of Pathology First Faculty of Medicine Charles University. Ovary

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

ab Endometrial cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

UICC TNM 8 th Edition Errata

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

Protocol for the Examination of Specimens From Patients With Primary Tumors of the Ovary, Fallopian Tube, or Peritoneum

STAGE CATEGORY DEFINITIONS

ab Nervous system tumor tissue array, 102 cases (1.5mm)

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Enrollment Form: Pancreas

Icd 10 ovarian stroma

Springer Healthcare. Understanding and Diagnosing Ovarian Cancer. Concise Reference: Krishnansu S Tewari, Bradley J Monk

ab Lung cancer tissue array paired with normal tissues, 16 cases, 48 samples (2mm), set 2

Janjira Petsuksiri, M.D

Hitting the High Points Gynecologic Oncology Review

ab Lymphoma tissue array of 102 cases (1.5mm) set 2

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

The 8th Edition Lung Cancer Stage Classification

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Pathology of the female genital tract

بسم هللا الرحمن الرحيم. Prof soha Talaat

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

ab Lymphoma tissue array of 102 cases (1.5mm) set 1

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

This protocol is intended to assist pathologists in providing

ab Cervical cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

Interactive Staging Bee

ab Melanoma (primary and metastatic) tissue array, 48 cases, 96 samples (1.5mm)

47. Melanoma of the Skin

Cervical Cancer: 2018 FIGO Staging

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

Stage: The Language of Cancer

Fallopian Tube. Protocol applies to all invasive carcinomas of the fallopian tube.

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Role of Diffusion weighted MR Imaging in the Evaluation of Ovarian Tumors

Internal Medicine Half Day. July 18, 2006

Chapter 2 Staging of Breast Cancer

Approach to imaging of the ovaries

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

Multi-normal human tissues, FDA, 96 samples, 35 organs/sites from three individuals (1.5mm)

ab Nervous system glioma tissue array, 48 cases, 96 samples (1.5mm)

Gynaecological Pathology Reporting. Peritoneal cytology Tony Williams Birmingham

Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters

Cancer of the ovary, fallopian tube, and peritoneum

2/24/19. Ovarian pathology: IOTA ADNEXAL MASSES. Content. IOTA terms for description of an adnexal mass. IOTA terms for description of an adnexal mass

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

Protocol for the Examination of Specimens From Patients With Primary Tumors of the Ovary, Fallopian Tube, or Peritoneum

Testicular Malignancies /8/15

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

Definition of Synoptic Reporting

Transcription:

Cat No: OVC2281 - Ovary cancer tissue array Lot# Cores Size Cut Format QA/QC OVC228101 228 1.1mm 4um 12X19 H&E, IHC anti- Cytokeratin Recommended applications: For Research use only. RNA or protein ovary cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization. Description: Ovary cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. There may be >5% tissue core loss, but the core retaining rate should be >90%. Position Sex Age Anatomic Site Pathology Grade Stage A01 F 21 Ovary Normal null null A02 F 46 Ovary Normal null null A03 F 34 Ovary Normal null null A04 F 65 Ovary Normal null null A05 F 55 Ovary Normal null null A06 F 51 Ovary Normal null null A07 F 46 Ovary Normal null null A08 F 52 Ovary Normal null null A09 F 35 Ovary Metastatic cancers derived from colon carcinoma null null A10 F 56 Ovary Serous cystadenocarcinoma II~III T3N0M1 A11 F 52 Ovary Serous cystadenocarcinoma II~III T1N0M0 A12 F 40 Ovary Metastatic colon signet ring cell carcinoma null null A13 F 51 Ovary Endometrioid adenocarcinoma III T1N0M0 A14 F 20 Ovary Serous cystadenocarcinoma I~II T1N0M0 A15 F 54 Ovary Thecoma null null A16 F 53 Ovary Serous cystadenocarcinoma III T2N0M0 A17 F 48 Ovary Endometrioid adenocarcinoma III T1N0M0 A18 F 44 Ovary Endometrioid adenocarcinoma II~III T1N0M0 A19 F 51 Ovary Serous cystadenocarcinoma III T3N1M1 B01 F 65 Ovary Endometrioid adenocarcinoma II~III T1N0M0 B02 F 67 Ovary Thecoma null null B03 F 39 Ovary Thecoma null null B04 F 47 Ovary Thecoma null null B05 F 43 Ovary Granulosa cell tumor null null B06 F 31 Ovary Teratoma null null B07 F 43 Ovary Serous cystadenocarcinoma III T1N0M0 B08 F 82 Ovary Endometrioid adenocarcinoma II T1N0M0 B09 F 43 Ovary Mucinous cystadenocarcinoma III T2N0M0 B10 F 63 Ovary Endometrioid adenocarcinoma III T2N0M0 B11 F 17 Ovary Dysgerminoma null T2N0M0 B12 F 54 Ovary Endometrioid adenocarcinoma III T2N0M0 B13 F 52 Ovary Granulosa cell tumor null null B14 F 34 Ovary Serous cystadenocarcinoma I T2N0M0 B15 F 55 Ovary Thecoma null null B16 F 58 Ovary Endometrioid adenocarcinoma III T2N0M0 B17 F 25 Ovary Endometrioid adenocarcinoma II T1N0M0 B18 F 48 Ovary Metastatic pancreatic adenocarcinoma null null B19 F 51 Ovary Endometrioid adenocarcinoma I T1N0M0 C01 F 50 Ovary Endometrioid adenocarcinoma I T3N1M1 C02 F 34 Ovary Endodermal sinus tumor null T1N0M0., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com

C03 F 34 Ovary Endodermal sinus tumor null T3N0M1 C04 F 48 Ovary Adenocarcinoma III T1N0M0 C05 F 22 Ovary Mucinous cystadenocarcinoma I T1N0M0 C06 F 33 Ovary Serous cystadenocarcinoma I T1N0M0 C07 F 57 Ovary Adenocarcinoma III T2N0M0 C08 F 68 Ovary Endometrioid adenocarcinoma III T2N0M0 C09 F 17 Ovary Endometrioid adenocarcinoma I T1N0M0 C10 F 38 Ovary Mucinous cystadenocarcinoma I T1N1M0 C11 F 31 Ovary Malignant teratoma null null C12 F 48 Ovary Mucinous cystadenocarcinoma III T1N0M0 C13 F 18 Ovary Serous cystadenocarcinoma II T1N0M0 C14 F 36 Ovary Leimyosarcoma? null T1N0M0 C15 F 42 Ovary Serous cystadenocarcinoma II~III T3N0M1 C16 F 23 Ovary Endodermal sinus tumor null null C17 F 45 Ovary Serous cystadenocarcinoma III T2N0M0 C18 F 18 Ovary Mucinous cystadenocarcinoma I T1N0M0 C19 F 48 Ovary Serous cystadenocarcinoma II T1N0M0 D01 F 49 Ovary Endometrioid adenocarcinoma III T1N0M0 D02 F 51 Ovary Endometrioid adenocarcinoma III T1N0M0 D03 F 65 Ovary Adenocarcinoma III T3N0M0 D04 F 51 Ovary Granulosa cell tumor null null D05 F 40 Ovary Leimyosarcoma? null null D06 F 55 Ovary Granulosa cell tumor null null D07 F 51 Ovary Serous cystadenocarcinoma III T1N0M0 D08 F 71 Ovary Endometrioid adenocarcinoma III T3N0M1 D09 F 24 Ovary Dysgerminoma null null D10 F 16 Ovary Granulosa cell tumor null null D11 F 58 Ovary Endometrioid adenocarcinoma III T3N0M1 D12 F 17 Ovary Dysgerminoma null null D13 F 50 Ovary Endometrioid adenocarcinoma III T1N0M0 D14 F 44 Ovary Serous cystadenocarcinoma III T2N0M0 D15 F 39 Ovary Endometrioid adenocarcinoma III T2N0M0 D16 F 35 Ovary Granulosa cell tumor null null D17 F 53 Ovary Mucinous cystadenocarcinoma II T1N0M0 D18 F 43 Ovary Endometrioid adenocarcinoma I T1N0M0 D19 F 74 Ovary Serous cystadenocarcinoma III T1N0M0 E01 F 52 Ovary Struma ovary null null E02 F 52 Ovary Endometrioid adenocarcinoma II T1N0M0 E03 F 56 Ovary Serous cystadenocarcinoma III T3N0M1 E04 F 54 Ovary Endometrioid adenocarcinoma III T3N0M1 E05 F 54 Ovary Serous cystadenocarcinoma III T3N0M1 E06 F 52 Ovary Clear cell carcinoma II T1N0M0 E07 F 25 Ovary Granulosa cell tumor null null E08 F 68 Ovary Endometrioid adenocarcinoma III T1N0M0 E09 F 51 Ovary Serous cystadenocarcinoma II~III T3N0M1 E10 F 55 Ovary Malignant teratoma null T1N0M0 E11 F 60 Ovary Serous cystadenocarcinoma III T2N0M0 E12 F 17 Ovary Malignant teratoma null null E13 F 61 Ovary Serous cystadenocarcinoma I~II T3N0M1 E14 F 26 Ovary Serous cystadenocarcinoma I T1N0M0 E15 F 24 Ovary Malignant teratoma null null E16 F 51 Ovary Endometrioid adenocarcinoma II T1N0M0 E17 F 23 Ovary Granulosa cell tumor null null E18 F 50 Ovary Endometrioid adenocarcinoma II T3N0M0 E19 F 39 Ovary Mucinous cystadenoma null null F01 F 37 Ovary Dysgerminoma null null F02 F 29 Ovary Serous cystadenocarcinoma I T1N0M0 F03 F 32 Ovary Clear cell carcinoma null T1N0M0 F04 F 54 Ovary Serous cystadenocarcinoma II T1N0M0 F05 F 57 Ovary Mucinous cystadenocarcinoma I T1N0M0 F06 F 22 Ovary Mucinous cystadenoma null null., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com

F07 F 55 Ovary Granulosa cell tumor null null F08 F 34 Ovary Granulosa cell tumor null null F09 F 56 Ovary Serous cystadenocarcinoma I~II T3N0M1 F10 F 55 Ovary Serous cystadenocarcinoma II~III T2N0M0 F11 F 55 Ovary Serous cystadenocarcinoma II T3N0M1 F12 F 29 Ovary Thecoma null null F13 F 41 Ovary Serous cystadenocarcinoma I T1N0M0 F14 F 45 Ovary Metastatic gastric adenocarcinoma null null F15 F 44 Ovary Malignant thecoma null null F16 F 72 Ovary Serous cystadenocarcinoma II T1N0M0 F17 F 30 Ovary Serous cystadenocarcinoma I T1N0M0 F18 F 50 Mesentary Metastatic ovary adenocarcinoma null null F19 F 47 Ovary Undifferentiated carcinoma null T3N0M0 G01 F 31 Ovary Endodermal sinus tumor null null G02 F 20 Ovary Endodermal sinus tumor null null G03 F 51 Ovary Embryonal carcinoma null null G04 F 47 Ovary Metastatic adenocarcinoma null null G05 F 41 Ovary Mucinous cystadenoma null null G06 F 58 Ovary Undifferentiated carcinoma null null G07 F 15 Ovary Malignant teratoma null null G08 F 54 Ovary Undifferentiated carcinoma null T3N0M0 G09 F 51 Ovary Mucinous cystadenocarcinoma III T2N0M0 G10 F 59 Ovary Thecoma null null G11 F 50 Ovary Endometrioid adenocarcinoma II T2N0M0 G12 F 45 Ovary Metastatic adenocarcinoma null null G13 F 23 Ovary Endodermal sinus tumor null null G14 F 54 Ovary Granulosa cell tumor null null G15 F 48 Ovary Undifferentiated carcinoma null T2N0M0 G16 F 54 Ovary Mucinous cystadenocarcinoma I~II T1N0M0 G17 F 52 Ovary Borderline mucinous cystadenoma null null G18 F 58 Ovary Neurofibroma null null G19 F 44 Ovary Endometrioid adenocarcinoma I T2N0M0 H01 F 44 Ovary Endometrioid adenocarcinoma II T2N0M0 H02 F 44 Ovary Granulosa cell tumor null null H03 F 52 Ovary Thecoma null null H04 F 38 Ovary Granulosa cell tumor null null H05 F 34 Ovary Serous cystadenocarcinoma null T2N0M0 H06 F 20 Ovary Mucinous cystadenocarcinoma I T1N0M0 H07 F 27 Ovary Borderline mucinous cystadenoma null T1N0M0 H08 F 58 Ovary Serous cystadenocarcinoma I~II T2N0M0 H09 F 57 Ovary Serous cystadenocarcinoma II T2N0M0 H10 F 48 Ovary Adenocarcinoma III T2N0M0 H11 F 50 Ovary Thecoma null null H12 F 28 Ovary Metastatic adenocarcinoma null null H13 F 51 Ovary Serous cystadenocarcinoma II T2N0M0 H14 F 62 Ovary Metastatic adenocarcinoma null null H15 F 42 Ovary Fibroma null null H16 F 57 Ovary Mucinous cystadenocarcinoma I~II T1N0M0 H17 F 31 Ovary Serous cystadenocarcinoma I T1N0M0 H18 F 42 Ovary Mucinous cystadenocarcinoma I~II T1N0M0 H19 F 54 Ovary Mucinous cystadenoma null null I01 F 39 Ovary Thecoma null null I02 F 54 Ovary Borderline serous cystadenoma null null I03 F 14 Ovary Dysgerminoma null T1N0M0 I04 F 18 Ovary Malignant teratoma null T1N0M0 I05 F 62 Ovary Mucinous cystadenoma null null I06 F 71 Ovary Serous cystadenocarcinoma III T3N0M1 I07 F 76 Ovary Mucinous cystadenocarcinoma I T1N0M0 I08 F 41 Ovary Endometrioid adenocarcinoma III T1N0M0 I09 F 60 Ovary Metastatic carcinoma null null I10 F 50 Ovary Serous cystadenocarcinoma I T1N0M0., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com

I11 F 35 Ovary Malignant teratoma null null I12 F 50 Ovary Serous cystadenocarcinoma III T3N0M1 I13 F 26 Ovary Serous cystadenocarcinoma I T1N0M0 I14 F 53 Ovary Serous cystadenocarcinoma III T1N0M0 I15 F 49 Ovary Brenner tumor null null I16 F 52 Ovary Serous cystadenocarcinoma III T1N0M0 I17 F 45 Ovary Mucinous cystadenocarcinoma I T3N0M1 I18 F 45 Ovary Mucinous cystadenocarcinoma I T3N0M1 I19 F 7 Ovary Dysgerminoma null null J01 F 44 Ovary Mucinous cystadenocarcinoma I~II T1N0M0 J02 F 29 Ovary Serous cystadenocarcinoma I T1N0M0 J03 F 59 Ovary Endometrioid adenocarcinoma III T1N0M0 J04 F 22 Ovary Metastatic adenocarcinoma null null J05 F 37 Ovary Adenocarcinoma III T3N0M0 J06 F 49 Ovary Dysgerminoma null null J07 F 53 Ovary Endometrioid adenocarcinoma III T1N0M0 J08 F 58 Ovary Serous cystadenocarcinoma III T1N0M0 J09 F 46 Ovary Mucinous cystadenocarcinoma II T1N0M0 J10 F 55 Ovary Granulosa cell tumor null T1N0M0 J11 F 50 Ovary Serous cystadenocarcinoma III T1N0M0 J12 F 55 Ovary Adenocarcinoma III T1N0M0 J13 F 56 Ovary Serous cystadenocarcinoma III T1N0M0 J14 F 48 Ovary Clear cell carcinoma null T1N0M0 J15 F 48 Ovary Malignant Mullerian tumor null T3N1M0 J16 F 43 Ovary Endometrioid adenocarcinoma II T3N0M0 J17 F 57 Ovary Mucinous cystadenoma null null J18 F 40 Ovary Dysgerminoma null null J19 F 50 Ovary Serous cystadenocarcinoma II T3N0M1 K01 F 27 Ovary Mucinous cystadenoma null null K02 F 51 Ovary Serous cystadenocarcinoma II T1N0M0 K03 F 38 Ovary Malignant thecoma null null K04 F 45 Ovary Serous cystadenoma null null K05 F 65 Ovary Adenocarcinoma III T3N1M0 K06 F 59 Ovary Serous cystadenocarcinoma II T3N0M1 K07 F 46 Ovary Adenocarcinoma III T1N0M0 K08 F 22 Ovary Dysgerminoma null null K09 F 71 Ovary Serous cystadenocarcinoma III T1N0M0 K10 F 60 Ovary Endometrioid adenocarcinoma III T3N0M0 K11 F 65 Ovary Serous cystadenocarcinoma I~II T2N0M0 K12 F 43 Ovary Malignant mesodermal tumor null null K13 F 55 Ovary Mucinous cystadenocarcinoma II T1N0M0 K14 F 57 Ovary Endometrioid adenocarcinoma III T3N0M1 K15 F 42 Ovary Metastatic adenocarcinoma null null K16 F 30 Ovary Metastatic adenocarcinoma null null K17 F 59 Ovary Serous cystadenocarcinoma III T3N0M1 K18 F 66 Ovary Serous cystadenocarcinoma II~III T1N0M0 K19 F 46 Ovary Serous cystadenocarcinoma III T2N0M0 L01 F 56 Ovary Serous cystadenocarcinoma III T1N0M0 L02 F 35 Ovary Transitional cell carcinoma II~III T1N0M0 L03 F 40 Ovary Serous cystadenocarcinoma III T3N1M1 L04 F 39 Ovary Mixed cell carcinoma null null L05 F 21 Ovary Endodermal sinus tumor null null L06 F 54 Ovary Endometrioid adenocarcinoma III T1N0M0 L07 F 53 Ovary Mucinous cystadenocarcinoma II T3N0M1 L08 F 61 Ovary Transitional cell carcinoma II T2N0M0 L09 F 69 Ovary Endometrioid adenocarcinoma null T1N0M0 L10 F 29 Ovary Teratoma null null L11 F 53 Ovary Endometrioid adenocarcinoma II T1N0M0 L12 F 25 Ovary Lymphoma, non-hodgkin lymphoma null null L13 F 62 Ovary Adenocarcinoma III null L14 F 30 Ovary Mucinous cystadenoma null null., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com

L15 F 28 Ovary Borderline serous cystadenoma null null L16 F 13 Ovary Malignant mesodermal tumor null null L17 F 65 Ovary Adenocarcinoma III T3N0M0 L18 F 36 Ovary Signet ring cell carcinoma null T2N0M0 L19 F 75 Ovary Serous cystadenocarcinoma II T2N0M0 Notes: Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide below as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information. Certified by: Fancai Li, M.D. TNM Classification: Ovary carcinoma T- Primary tumor TX - Primary tumor cannot be assessed TO - No evidence of primary tumor T1 - Tumor limited to the ovaries T1a - Tumor limited to one ovary; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings T1b - Tumor limited to both ovaries; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings T1c - Tumor limited to one or both ovaries with any or the following features; capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washing T2 - Tumor involves one or both ovaries with pelvic extension T2a - Extension and/or implants on uterus and/or tube(s); no malignant cells in ascites or peritoneal washings T2b - Extension to other pelvic tissue; no malignant cells in ascites or peritoneal washings T2c - Pelvic extension (T2a or T2b) with malignant cells in ascites or peritoneal washings T3 and/or N1 - Tumor involves both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis T3a - Microscopic peritoneal metastasis beyond pelvis T3b - Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension T3c and/or N1 - Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis N - Regional lymph nodes NX - Regional lymph nodes cannot be assessed NO - No regional lymph node metastasis N1 - Regional lymph node metastasis M - Distant metastasis MX - Distant metastasis cannot be assessed MO - No distant metastasis M1 - Distant metastasis (exclude peritoneal metastasis)., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com

Comparison between TNM vs. FIGO TNM category FIGO stage TNM category FIGO stage T1 I T3 and/or N1 III T1a IA T3a IIIA T1b IB T3b IIIB T1c IC T3c and/or N1 IIIC T2 II M1 IV T2a IIA T2b IIB T2c IIC TNM classification of malignant tumours, Fifth Edition (1997)., 2600 Hilltop Drive, Suite C310, Richmond, CA 94806 ; Fax: 510-225-1084; Email: info@pantomics.com